Therapeutic use of recombinant methionyl human leptin.

Abstract excerpt

Recombinant methionyl human leptin (r-metHuLeptin) was first used as a replacement therapy in patients bearing inactivating mutations in the leptin gene. In this indication, it was shown since 1999 to be very efficient in inducing a dramatic weight loss in rare children and adults with severe obesity due to the lack of leptin. These first clinical trials clearly showed that r-metHuLeptin acted centrally to reduce...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diabetes Mellitus
• Share to Leptin
• Share to Mutation